DefinitionThis section has been translated automatically.
Liraglutide (Victosa®) (once daily)
GLP-1 receptor agonist for the treatment of inadequately controlled type 2 DM as an adjunctive therapy to dietary changes and more exercise, possibly in addition to metformin or other antidiabetic drugs (adults, children and adolescents aged 10 and over).
Liraglutide (Saxenda®) (1x daily higher dosage)
for weight reduction as an accompanying therapy to dietary changes and more exercise (adults, children and adolescents aged 12 and over).
